February, 2021

article thumbnail

Jazz Pharmaceuticals to acquire GW Pharma for $7.2bn

Pharma Times

Jazz will add GW's plant-derived cannabinoid treatment Epidiolex to its roster

164
164
article thumbnail

Johnson & Johnson Will Test its Vaccine in Infants

NY Times

The company’s coming trials will also involve pregnant women and people whose immune systems are compromised.

Immunity 144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AstraZeneca/Oxford to trial COVID-19 vaccine in children

Outsourcing Pharma

A new trial for the AstraZeneca/Oxford COVID-19 vaccine will investigate the efficacy of the vaccine in children aged six and over.

Vaccines 144
article thumbnail

White paper reveals pathway for digital therapeutics use in Italy

pharmaphorum

A white paper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month. The book features insights and recommendations from 40 leading experts in the field, who hope that Italy will begin to follow in the footsteps of early adopters of digital therapeutics such as Germany, France and

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Say ‘NO’ to bad contracts

Drug Patent Watch

Are you tired of having to naviagate complicated contracts to access the information you need? Let DrugPatentWatch free you from weeks of negotiating complex contracts and let you focus on…. The post Say ‘NO’ to bad contracts appeared first on DrugPatentWatch - Make Better Decisions.

109
109

More Trending

article thumbnail

Synairgen’s inhaled COVID-19 treatment included in US trial

Pharma Times

Trial is sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID)

163
163
article thumbnail

Semaglutide Brings Significant Weight Loss in Obese Patients

NY Times

In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.

Diabetes 132
article thumbnail

Family cancer experience informs eHealth company

Outsourcing Pharma

The founder of Andaman7âs leukemia diagnosis, and his sonâs experience with bone cancer, have helped inform the firm's tech and patient-centric approach.

126
126
article thumbnail

LSD biotech MindMed buys digital trial firm HealthMode

pharmaphorum

Psychedelic medicine biotech MindMed is to acquire digital medicine and therapeutics startup HealthMode for around $32.2 million, which uses artificial intelligence (AI) technology to speed up drug development. The move will also see ex-Pfizer digital medicine executive Dr Daniel Karlin join the MindMed executive team, along with former Google AI guru Bradford Cross.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

DrugPatentWatch featured in Inc Magazine

Drug Patent Watch

DrugPatentWatch was featured in a recent article by Inc. Magazine. In their coverage of Mark Cuban’s new pharma company, they cited our published interview where Mark Cuban Sounds off on Drug Prices.…. The post DrugPatentWatch featured in Inc Magazine appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Webinar Recap – Video, Voice, and Virtual: Applying New Digital Technology to Enhance Customer Experience with PMN

Pharma Marketing Network

Moderator and Panelists: Amy Turnquist , EVP, Digital, eHealthcare Solutions (Moderator). Ryan Billings , U.S. Oncology Digital Marketing & Customer Experience at GSK. Desiree Priestley , Director, Patient Support Strategy & Insights at Otsuka America Pharmaceutical. Kristen Palmer Winters , Customer Experience (CX), Americas Hub, Digital & Commercial Innovation, Bayer.

98
article thumbnail

Millions could benefit from genetic screening before prescribing, new research finds

Pharma Times

Research led by the University of East Anglia in collaboration Boots UK and Leiden University

142
142
article thumbnail

McKinsey Settles for $573 Million Over Role in Opioid Crisis

NY Times

The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.

124
124
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Blockchain could accelerate drug development: Bloqcube

Outsourcing Pharma

With pharma firms seeking solutions to get products in the hands of patients faster, one company believes blockchain technology could provide answers.

article thumbnail

Why we need the human element of remote clinical trials

pharmaphorum

Over the last year, we’ve noticed that “connectivity” doesn’t always equate to “connected” – and that’s just as true in the realm of clinical trials as it is in our personal lives. Amanda Barrell reports from a panel at the Patients as Partners Europe conference on remote clinical trials. Decentralised trials have been growing in popularity in recent years, and the COVID-19 pandemic has served to accelerate that progress.

Hospitals 133
article thumbnail

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA

Drug Patent Watch

This article was originally published by Ioana Gherghescu and Begoña Delgado-Charro in Pharmaceutics 2021, 13(1) under a Creative Commons Attribution License. Abstract Biosimilar medicines expand the biotherapeutic market and improve…. The post The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

2020 OPDP Enforcement

Eye on FDA

Last month we looked at a review of FDA press releases for last year and as one might have expected, there was an enormous spike in communications as a result of the COVID-19 pandemic. Looking now to a review of enforcement by the Office of Prescription Drug Promotion (OPDP) in 2020, we see a different picture. We instead see the same pace as we have the past several years – that is anemic levels of enforcement.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

NHS to open mental health support hubs dedicated to staff

Pharma Times

Services will be offered to staff who have been affected by the COVID-19 pandemic

138
138
article thumbnail

Israel’s Vaccination Results Point a Way Out of Virus Pandemic

NY Times

Covid cases fell dramatically and quickly among people who were vaccinated, Israeli studies found. It’s the strongest evidence yet that a robust vaccination program can tame the pandemic.

Vaccines 111
article thumbnail

Decentralized trials more pandemic-proof than traditional: study

Outsourcing Pharma

A study by two trial technology firms reportedly indicates that decentralized trials are outperforming on-site in recruitment, retention and other aspects.

105
105
article thumbnail

Triple Negative Breast Cancer Drug Development Digital Summit

pharmaphorum

Improving the Safety, Efficacy & Predictability of Monotherapy & Combinatorial Therapies to Fast-track the Discovery & Development of TNBC Treatments to Reach Patients in Need. This is the primary industry platform specifically dedicated to providing you insight into the latest developments of safe and efficacious blockbuster therapies to treat triple negative breast cancer.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Which pharmaceutical companies have the most liquid dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most liquid dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most liquid dosed drugs…. The post Which pharmaceutical companies have the most liquid dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Novartis Piqray(R) – First and only treatment specially for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer receives HSA approval

Pharma Mirror

Novartis announced the Health Sciences Authority (HSA) has approved* Piqray®, an ?-specific class I phosphatidylinositol-3-kinase (PIK3CA) inhibitor, for the treatment of postmenopausal women, and men, with hormone receptor positive (HR+), human epidermal growth factor receptor 2 (HER2-) negative, advanced breast cancer with a PIK3CA mutation in combination with fulvestrant after disease progression following an endocrine-based regimen.

52
article thumbnail

Parkinson’s UK creates Vivifi Biotech to research ‘promising’ experimental treatment

Pharma Times

Biotech company will be dedicated to accelerating development of potential treatment

137
137
article thumbnail

How Scientists Shot Down Cancer’s ‘Death Star’

NY Times

No drug could touch a quivering protein implicated in a variety of tumors. Then one chemist saw an opening.

104
104
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.